This paper examines the expanding role of Clinical Trial Educators (CTEs) in pulmonary arterial hypertension research. It explains how CTEs support recruitment, site education, protocol adherence, and patient retention in a highly specialized and competitive trial environment. The paper presents case examples demonstrating improved enrollment, reduced screen failures, and enhanced site performance. It also outlines best practices for deploying CTEs globally and integrating them into trial operations. The paper concludes that CTEs are a critical enabler of efficiency and quality in PAH clinical development.

Join for free to read